Contract Research Organisations

News

Cocrystal selects hVIVO as CRO for Phase IIa Influenza antiviral trial

The trial of CC-42344 in participants who are challenged with influenza A is planned to begin in the second half of next year.

Vishnu Priyan
Features

Just-in-time: on schedule to rescue the clinical trial supply chain?

Buyer's Guides

Contract Research Organizations for the Clinical Trials Industry